ED stock · RNXT stock

ED vs RNXT · P/E 18, rev $15.26B vs rev $266.0K

Consolidated Edison Inc (ED) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.

Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.

RenovoRx Inc (RNXT) is a biotechnology company listed on US.

Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.

Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.

ED currently screens at market cap $36.02B and trailing P/E 18.3. RNXT currently screens at market cap $47.0M.

Not investment advice. Open the ED and RNXT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons